Nanjing Vishee Medical Technology Co Ltd
Nanjing Vishee Medical Technology Co., Ltd provides rehabilitation meditation products and solutions in China and internationally. The company offers MagNeuro, a transcranial magnetic stimulation (TMS) for use in anxiety disorders, movement disorders, and ADHD applications; MagNeuro ONE, a TMS therapy system with navigation for use in anxiety disorders applications; and MagBelle, a pelvic floor m… Read more
Nanjing Vishee Medical Technology Co Ltd (688580) - Total Assets
Latest total assets as of September 2025: CN¥1.82 Billion CNY
Based on the latest financial reports, Nanjing Vishee Medical Technology Co Ltd (688580) holds total assets worth CN¥1.82 Billion CNY as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Nanjing Vishee Medical Technology Co Ltd - Total Assets Trend (2013–2024)
This chart illustrates how Nanjing Vishee Medical Technology Co Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Nanjing Vishee Medical Technology Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Nanjing Vishee Medical Technology Co Ltd's total assets of CN¥1.82 Billion consist of 63.9% current assets and 36.1% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 58.7% |
| Accounts Receivable | CN¥30.47 Million | 1.7% |
| Inventory | CN¥38.74 Million | 2.1% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥127.68 Million | 7.0% |
| Goodwill | CN¥69.31 Million | 3.8% |
Asset Composition Trend (2013–2024)
This chart illustrates how Nanjing Vishee Medical Technology Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Nanjing Vishee Medical Technology Co Ltd's current assets represent 63.9% of total assets in 2024, a decrease from 93.4% in 2013.
- Cash Position: Cash and equivalents constituted 58.7% of total assets in 2024, up from 11.0% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 10.0% of total assets, an increase from 1.0% in 2013.
- Asset Diversification: The largest asset category is intangible assets at 7.0% of total assets.
Nanjing Vishee Medical Technology Co Ltd Competitors by Total Assets
Key competitors of Nanjing Vishee Medical Technology Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Nanjing Vishee Medical Technology Co Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Nanjing Vishee Medical Technology Co Ltd generates 0.22x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Nanjing Vishee Medical Technology Co Ltd generates $5.60 in net profit.
Nanjing Vishee Medical Technology Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.82 | 8.60 | 11.03 |
| Quick Ratio | 6.54 | 8.31 | 10.74 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥958.45 Million | CN¥ 1.00 Billion | CN¥ 1.29 Billion |
Nanjing Vishee Medical Technology Co Ltd - Advanced Valuation Insights
This section examines the relationship between Nanjing Vishee Medical Technology Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.50 |
| Latest Market Cap to Assets Ratio | 0.16 |
| Asset Growth Rate (YoY) | 0.8% |
| Total Assets | CN¥1.82 Billion |
| Market Capitalization | $293.70 Million USD |
Valuation Analysis
Below Book Valuation: The market values Nanjing Vishee Medical Technology Co Ltd's assets below their book value (0.16 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Nanjing Vishee Medical Technology Co Ltd's assets grew by 0.8% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Nanjing Vishee Medical Technology Co Ltd (2013–2024)
The table below shows the annual total assets of Nanjing Vishee Medical Technology Co Ltd from 2013 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.82 Billion | +0.79% |
| 2023-12-31 | CN¥1.81 Billion | +7.23% |
| 2022-12-31 | CN¥1.68 Billion | +2.77% |
| 2021-12-31 | CN¥1.64 Billion | +6.38% |
| 2020-12-31 | CN¥1.54 Billion | +281.09% |
| 2019-12-31 | CN¥404.22 Million | +31.09% |
| 2018-12-31 | CN¥308.36 Million | +25.06% |
| 2017-12-31 | CN¥246.57 Million | +45.29% |
| 2016-12-31 | CN¥169.71 Million | +33.90% |
| 2015-12-31 | CN¥126.74 Million | +55.82% |
| 2014-12-31 | CN¥81.34 Million | +13.77% |
| 2013-12-31 | CN¥71.50 Million | -- |